Institutional investors hold a majority ownership of ABT through the 77.75% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2016, these large investors purchased a net $15.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 6.7 Million shares of Abbott Laboratories
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 4.0 Million shares of Abbott Laboratories
RENAISSANCE TECHNOLOGIES LLC Bought 3.5 Million shares of Abbott Laboratories